Click Here to return To Results

 

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS Neurol 68:1390-1401, Miller,D.H.,et al, 2007 See this aricle in Pubmed Article Abstract Natalizumab has a sustained effect in preventing the formation of new lesions in patients with relapsing multiple sclerosis.

Related Tags

(click to filter results - removes previous filter) efficacy monoclonal antibodies MRI,abnormal MRI,serial multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,treatment of natalizumab

Click Here to return To Results